Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging

• Buck Institute’s deployment of Nautilus’ instrument generates tau proteoform data, providing external validation of the company’s next-generation single-molecule proteomics platform • Joint research...
October 28, 2025 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology Reports Third Quarter 2025 Financial Results

SEATTLE, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial...
October 07, 2025 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025

SEATTLE, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will...
August 27, 2025 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology to Participate in Upcoming September Investor Conferences

SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company...
July 31, 2025 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology Reports Second Quarter 2025 Financial Results

SEATTLE, July 31, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial...
July 30, 2025 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics

• Allen Institute to employ Iterative Mapping, Nautilus’ single-molecule proteomics method, to investigate connection between tau protein and Alzheimer’s disease • Agreement links the organizations’...
July 15, 2025 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025

SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...
May 27, 2025 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

SEATTLE, May 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...
April 29, 2025 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology Reports First Quarter 2025 Financial Results

SEATTLE, April 29, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial...
April 16, 2025 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025

SEATTLE, April 16, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today announced it will...